impact of dmb compared with za on renal function in the treatment of myeloma bone disease
Published 7 years ago • 64 plays • Length 3:49Download video MP4
Download video MP3
Similar videos
-
9:03
noopur raje, md: denosumab versus za for myeloma-related bone disease
-
54:41
the importance of bone health and treatment updates in multiple myeloma
-
33:23
updates on managing bone disease in multiple myeloma
-
11:41
multiple myeloma - signs and symptoms, pathophysiology, treatment
-
31:03
2019 multiple myeloma symposium | managing bone disease
-
32:50
myeloma treatment: a guide for patients and families
-
29:24
managing bone disease in multiple myeloma
-
30:03
mcrt jackson 2017: understanding multiple myeloma by noopur raje, md
-
44:07
bone disease in multiple myeloma
-
0:52
dr. martin on fda approval of denosumab in multiple myeloma
-
42:05
how to manage bone disease in multiple myeloma by dr. andrew yee
-
29:08
newly diagnosed multiple myeloma, response, bone health, renal health, mrd, survivorship care
-
3:39
what treatment options are available to manage myeloma-related bone disease?
-
1:00
multiple myeloma - signs and symptoms #myeloma #cancer
-
37:04
updates in managing bone disease in multiple myeloma | dana-farber cancer institute
-
34:14
multiple myeloma symposium: a patient's perspective | dana-farber cancer institute
-
4:27
evaluating efficacy of denosumab compared with zoledronic acid in symptomatic myeloma
-
2:29
outcomes in multiple myeloma based on comorbidities and race
-
34:48
multiple myeloma symposium: bone health | dana-farber cancer institute